The battle against polio, a devastating disease, continues globally, and Zimbabwe is at the forefront of a vital regional effort to protect children. Following a successful campaign to contain a circulating vaccine-derived poliovirus type 2 (cVDPV2) outbreak within its borders, Zimbabwe has now joined forces with several Southern African nations in a synchronized vaccination drive. This collaborative initiative, which saw three successful rounds of immunization using the specialized novel oral polio vaccine type 2 (nOPV2), marks a significant stride towards strengthening regional immunity and ensuring a polio-free future for countless children. ## The Polio Threat: Understanding the Virus Polio is a highly infectious disease caused by the poliovirus, which primarily attacks the nervous system. In its most severe forms, it can lead to paralysis, most commonly in the legs, and in some cases, can even be fatal. There is no cure for polio; prevention through vaccination is the only way to safeguard individuals and communities. The virus typically spreads from person to person through contaminated food or water, often via the fecal-oral route, making crowded areas and regions with less developed sanitation particularly vulnerable. While significant progress has been made in eradicating wild poliovirus globally, a different challenge has emerged: circulating vaccine-derived poliovirus (cVDPV). These rare strains occur when the weakened live poliovirus in some oral polio vaccines (OPV) circulates in under-immunized populations for an extended period. Over time, it can genetically change, regaining the ability to cause paralysis. cVDPV Type 2 (cVDPV2) is currently the most prevalent form of vaccine-derived poliovirus, posing a persistent threat to global eradication efforts. ## A New Tool: The Novel Oral Polio Vaccine (nOPV2) The global fight against cVDPV2 has been significantly bolstered by the development and deployment of the novel oral polio vaccine type 2, or nOPV2. This innovative vaccine is a modified version of the traditional Type 2 oral polio vaccine. It is designed to be more genetically stable, meaning it is much less likely to revert to a form that can cause paralysis, even in populations with low immunity. This makes nOPV2 a crucial tool for safely and effectively interrupting cVDPV2 outbreaks and preventing their re-establishment, without inadvertently contributing to new risks. ## Zimbabwe's Journey: From Outbreak to Control Zimbabwe has demonstrated remarkable resilience in its fight against polio. The country faced a significant challenge with a cVDPV2 outbreak declared in October 2023. Swift and decisive action, including four nationwide vaccination campaigns, significantly bolstered surveillance efforts, and enhanced outbreak response measures, led to a remarkable turnaround. As of June 2024, no cVDPV2 has been detected within the country. This achievement underscores Zimbabwe's commitment to public health and the effectiveness of its national health programs. However, the threat of polio is not confined by national borders. Ongoing cVDPV2 outbreaks in neighboring countries serve as a stark reminder of the persistent risk of cross-border virus importation. Maintaining Zimbabwe's polio-free status requires not just strong internal measures but also a robust, coordinated regional defense. The virus knows no boundaries, and neither should the response. ## A Coordinated Regional Shield: The Synchronized Campaign Recognizing this interconnected risk, Zimbabwe proactively joined forces with Mozambique, Malawi, Zambia, Namibia, and Botswana in a synchronized sub-regional vaccination endeavor. This concerted action aimed to create a robust shield against poliovirus transmission across Southern Africa. The strategy involved targeting specific districts identified through detailed risk assessments, with a particular focus on border areas and densely populated urban centers where the risk of virus importation and spread is highest. Three rounds of subnational immunization campaigns were meticulously planned and executed across 27 high-risk districts spanning nine provinces, primarily focusing on protecting children under five years of age, who are most vulnerable to the disease. ## Mobilizing for Health: The Extensive Support Network The success of such a large-scale public health initiative hinges on extensive collaboration and mobilization. The Ministry of Health and Child Care (MOHCC) of Zimbabwe led this monumental effort, bolstered by unwavering support from a consortium of international partners. Key collaborators included the World Health Organization (WHO), UNICEF, Rotary International, the United States Centers for Disease Control and Prevention (CDC), and other vital partners within the Global Polio Eradication Initiative (GPEI). This powerful alliance mobilized over 6,000 dedicated personnel, encompassing healthcare workers, village health workers, community volunteers, and health managers at both national and subnational levels. To further strengthen the response, nine national surge consultants were strategically deployed to enhance critical areas such as surveillance, campaign implementation, community engagement, social mobilization, logistics, cold chain management for vaccines, data analysis, and overall coordination. ## Reaching Every Child: Campaign Execution and Impact To ensure maximum reach and impact, vaccination services were delivered through a combination of facility-based sites and extensive community outreach. The primary and most effective approach was door-to-door vaccination, where dedicated teams brought the life-saving nOPV2 vaccine directly to households. This method was crucial for reaching every eligible child, especially those in remote or hard-to-reach areas who might otherwise miss out on immunization. By taking vaccines directly to families, the campaigns successfully sustained high population immunity in targeted districts, significantly reducing the risk of poliovirus re-emergence and transmission across the entire country. The three nOPV2 vaccination campaigns were conducted with remarkable precision and dedication. The first round took place from April 20–23, 2026, followed by the second from June 2–5, and the third from July 7–10. Impressively, campaign quality and operational performance steadily improved across these rounds, reflecting robust planning, meticulous supervision, and increasingly effective community engagement. The numbers speak volumes: 936,618 children were vaccinated in the first round, 997,941 in the second, and 1,025,806 in the third. In total, nearly three million doses of nOPV2 were administered, profoundly strengthening immunity among vulnerable children in Zimbabwe's highest-risk regions. ## Beyond Vaccination: Sustaining Vigilance The comprehensive response extended far beyond mere vaccination. It has critically strengthened crucial public health infrastructures. Acute flaccid paralysis (AFP) surveillance, the primary method for detecting polio cases, has been enhanced, alongside environmental surveillance, which involves testing wastewater for the presence of poliovirus. Cross-border collaboration has been invigorated, allowing for better coordination and information sharing among neighboring countries. The initiative also provided a significant boost to routine immunization services, ensuring that children continue to receive all essential vaccines. Furthermore, monitoring and supervision systems have been reinforced, ensuring accountability and efficiency. Regular coordination meetings at both national and subregional levels have been instrumental in aligning activities and swiftly addressing any operational challenges that arose. ## Voices of Dedication and Vision Reflecting on the success, Sr. Chipangura, Nurse in Charge at Tariro Clinic in Harare South District, emphasized the power of teamwork: “The success of every vaccination campaign depends on teamwork. From activities carried out at health facilities to door-to-door outreach in communities, every health worker plays an important role in ensuring that children are protected against vaccine-preventable diseases. Seeing our teams work together to reach families and ensure that no child is missed gives me confidence that we can keep our communities safe from polio.” Dr. Tiruneh Desta, WHO Representative to Zimbabwe, underscored the broader vision: “The fight against polio is a race to reach every child, everywhere, before the virus does. WHO remains committed to supporting the Government of Zimbabwe and partners through technical expertise, surveillance, operational coordination, and community engagement to ensure that life-saving vaccines reach all eligible children. Zimbabwe’s synchronized vaccination campaign reflects the power of regional solidarity and collective action in stopping poliovirus transmission.” ## Forward Momentum: Securing a Polio-Free Future The successful implementation of these synchronized campaigns has undeniably fortified Zimbabwe’s population immunity, substantially reducing the risk of re-establishment and spread of type 2 polioviruses. As this vital regional response continues, Zimbabwe is intensifying its preparedness measures, bolstering surveillance, strengthening routine immunization programs, and enhancing community engagement. Furthermore, strict protocols are in place to ensure full accountability for all nOPV2 vaccine vials, proper waste management, and reinforced laboratory surveillance capacity. This synchronized regional response represents another crucial step towards achieving a truly polio-free future for children in Zimbabwe and across the entire Southern African region, moving the world closer to eradicating polio once and for all.